Sanofi-Aventis, the biggest player onRomania's pharmaceutical market, which owns Zentiva producer, isset to start exporting ten drugs produced in the plant it owns inBucharest in February-March 2011.
Delivers to foreign markets will go to countries such as France,Germany, Italy, United Kingdom, Portugal. At present, the companyhas a small presence abroad, in the Republic of Moldova, but higherexport volumes will be reached with the ten products aimed atWestern markets.
The drugs will be from areas such as urology and hypertension, aswell as others. Dan Ivan, country head with Sanofi-Aventis andchairman of Zentiva SA board, explained the Bucharest plant hasseveral advantages.
"The production capacity, of above 2 billion tablets, is not 100%used," Dan Ivan said.
The company's representatives did not provide any data on theestimated value of exports or their weight in the plant's annualproduction.
Pentru alte știri, analize, articole și informații din business în timp real urmărește Ziarul Financiar pe WhatsApp Channels
